US cancer screenings slow to recover from initial pandemic dip
Early in COVID-19, rates of lung and breast cancer screenings among Medicare enrollees were 24% and 17%, respectively, below expected rates, rising to -14% and -4% later on.
Early in COVID-19, rates of lung and breast cancer screenings among Medicare enrollees were 24% and 17%, respectively, below expected rates, rising to -14% and -4% later on.
The results suggest that waning SARS-CoV-2 immunity levels over time can lead to reinfections and a new pandemic wave, the authors say.
Of those who had long COVID, 61% had been hospitalized after contracting the virus.
University of Minnesota http://twin-cities.umn.edu/ 612-625-5000 A strategy designed by the Centers for Disease Control and Prevention (CDC) to prevent one of the leading causes of…
University of Minnesota http://twin-cities.umn.edu/ 612-625-5000 With the bungled responses to the COVID-19 pandemic and a recent mpox outbreak still fresh in mind, a new report…
University of Minnesota http://twin-cities.umn.edu/ 612-625-5000 With the bungled responses to the COVID-19 pandemic and a recent mpox outbreak still fresh in mind, a new report…
University of Minnesota http://twin-cities.umn.edu/ 612-625-5000 A strategy designed by the Centers for Disease Control and Prevention (CDC) to prevent one of the leading causes of…
Patients also had a significantly lower rate of early-stage cancer and a significantly higher rate of advanced tumors.
The country last declared an emergency owing to dengue in 2012.
Among participants from Finland and the Netherlands, a greater abundance of butyrate-producing bacteria in the gut was linked to reduced risk of hospitalization from infection.
Pfizer’s novel combination antibiotic Emblaveo (aztreonam-avibactam) moves a step closer to regulatory approval in Europe.